Immune reactions in patients with superficial bladder cancer after intradermal and intravesical treatment with bacillus Calmette-Guérin

Intracavitary Bacillus Calmette-Guerin in the Treatment of Superficial Bladder Tumors

2016 • 1,466 citations

Intracavitary bacillus Calmette-Grerin in the treatement of superficial bladder tumors

1976 • 978 citations

Established cell line of urinary bladder carcinoma (T24) containing tumour‐specific antigen

1973 • 514 citations

Demonstration of antibodies against human malignant melanoma by immunofluorescence.

1968 • 390 citations

Immunotherapy of Cancer: Regression of Intradermal Tumors and Prevention of Growth of Lymph Node Metastases After Intralesional Injection of Living <italic>Mycobacterium bovis</italic>

1972 • 355 citations

Experience with Bacillus Calmette-Guerin in Patients with Superficial Bladder Carcinoma

1982 • 314 citations

Bacillus Calmette-Guerin Immunotherapy for Bladder Cancer

1985 • 300 citations

Cellular and humoral immune responses to human urinary bladder carcinomas

1970 • 294 citations

Cell surface antigens of human bladder cancer defined by mouse monoclonal antibodies.

1984 • 273 citations

A prospective randomized trial of maintenance versus nonmaintenance intravesical bacillus Calmette-Guérin therapy of superficial bladder cancer.

1987 • 227 citations

Cellular immunity to human urinary bladder carcinoma. I. Correlation to clinical stage and radiotherapy

1972 • 225 citations

Immunopotentiation With BeG. I. Immune Response to Different Strains and Preparations2

1973 • 186 citations

Intravesical Bacillus Calmette-Guerin Therapy for Superficial Bladder Cancer: Effect of Bacillus Calmette-Guerin Viability on Treatment Results

1985 • 150 citations

Sequential studies on cell‐mediated tumor immunity and blocking serum activity in ten patients with malignant melanoma

1973 • 148 citations

BCG immunotherapy of bladder cancer: Inhibition of tumor recurrence and associated immune responses

1981 • 108 citations

Intravesical administration of bacillus Calmette-Guérin in patients with recurrent superficial carcinoma of the urinary bladder: report of a prospective, randomized trial.

1985 • 88 citations

Reduction of bladder tumor growth in mice treated with intravesical Bacillus Calmette-Guérin and its correlation with Bacillus Calmette-Guérin viability and natural killer cell activity.

1983 • 71 citations

Monoclonal antibodies to antigens associated with transitional cell carcinoma of the human urinary bladder

1984 • 63 citations

Antibody responses to Bacillus Calmette-Guérin during immunotherapy in bladder cancer patients.

1981 • 48 citations

Monoclonal Antibodies Against Cell Surface Antigens Present on Human Urinary Bladder Cancer Cells<xref ref-type="fn" rid="FN2">2</xref>

1984 • 47 citations

Monoclonal antibodies to antigens associated with transitional cell carcinoma of the human urinary bladder

1984 • 46 citations

Induction of Natural Killer Cell Activity and Allocytotoxicity in Human Peripheral Blood Lymphocytes after Mixed Lymphocyte Culture

1981 • 45 citations

Production and characterization of mouse monoclonal antibodies to human bladder tumor-associated antigens.

1985 • 45 citations

Inhibition of murine bladder tumor growth by bacille Calmette-Guerin: Lack of a role of natural killer cells

1986 • 43 citations

Human bladder cancer cell-surface antigens recognized by murine monoclonal antibodies raised against T24 bladder cancer cells.

1985 • 41 citations

Lymphocyte‐mediated lysis of tumor cells in vitro (ADCC), induced by serum antibodies from patients with urinary bladder carcinoma or from controls

1980 • 31 citations

Role of immunotherapy in the prevention of recurrence and invasion of urothelial bladder tumors: a review

1985 • 26 citations

Immunotherapy by Intralesional Injection of BCG Cell Walls or Live BCG in Bovine Ocular Squamous Cell Carcinoma: A Preliminary Report<xref ref-type="fn" rid="fn2">2</xref>

1982 • 22 citations

A ⁵¹chromium isotope release assay for detecting cytotoxicity to human bladder carcinoma

1977 • 20 citations

Immunosuppressive factors released by transforming lymphocytes in the delayed hypersensitivity skin response to tuberculin.

1973 • 20 citations

Human cell-mediated cytotoxicity estimated by lymphocyte titration.

1976 • 19 citations

Follow-up investigations of bladder cancer patients by titration of natural and specific lymphocyte-mediated cytotoxicity

1981 • 17 citations

Purification and characterization of an immunosuppressive factor from ovarian cancer ascites fluid

1981 • 15 citations

Lymphocyte Antibody Interaction in Cytotoxicity Against Human Transitional Cell Carcinoma

1975 • 14 citations

Immunological studies in a double blind randomized trial comparing intrapleural BCG against placebo in patients with resected stage I non-small cell lung cancer

1982 • 13 citations

Humoral and cellular immune reactions against tumor cells in patients with urinary bladder carcinoma

1983 • 13 citations

Induction of suppressor cell activities in normal lymphocytes by sera from gastric cancer patients.

1983 • 12 citations

BCG preparations, cultured homogeneously dispersed or as a surface pellicle, elicit different immunopotentiating effects but have similar antitumor activity in a murine fibrosarcoma

1981 • 11 citations

Tumour-Associated Antibodies against Renal Cell Carcinomas Detected by Immunofluorescence

1975 • 10 citations

Serial immune function testing to predict clinical disease relapse in patients with solid tumors

1983 • 9 citations

Autochthonous humoral and cellular immunoreactivity to colorectal carcinoma: Prognostic significance in 400 patients

1980 • 9 citations

Effect of BCG Immunotherapy on Cell-Mediated Cytotoxicity in Bladder Cancer Patients following Surgical Treatment

1981 • 8 citations

[Immunotherapy of cancer].

1976 • 8 citations

Immune reactivity in cattle with ocular squamous cell carcinoma after intralesional BCG immunotherapy

1986 • 7 citations

Intravesical and intradermal Bacillus Calmette-Guérin application. A phase I study to the toxicity of a Dutch Bacillus Calmette-Guérin preparation in patients with superficial bladder cancer.

1988 • 6 citations

Tumor-specific antibodies in sera from patients with squamous cell carcinoma of the uterine cervix

1981 • 5 citations

Preliminary results on the use of the humoral immune response as a serum marker in patients with bladder tumors

1985 • 2 citations

A follow-up study of urinary bladder patients tested for tumour-related lymphocyte-mediated cytotoxicity

1982 • 2 citations

LYMPHOCYTE CYTOTOXICITY AGAINST AUTOLOGOUS BLADDER TUMOR CELLS IN HUMANS, INVESTIGATED BY USE OF A CHROMIUM‐51 RELEASE ASSAY

1981 • 1 citations

Active, specific immunotherapy of stage III breast cancer

1980 • 1 citations